Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001516551-25-000042
Filing Date
2025-05-08
Accepted
2025-05-08 16:03:41
Documents
60
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q skye-20250331.htm   iXBRL 10-Q 572060
2 EX-31.1 skye-20250331xex311xsectio.htm EX-31.1 10495
3 EX-31.2 skye-20250331xex312xsectio.htm EX-31.2 11024
4 EX-32.1 skye-20250331xex321xsectio.htm EX-32.1 5076
5 EX-32.2 skye-20250331xex322xsectio.htm EX-32.2 5216
  Complete submission text file 0001516551-25-000042.txt   4049463

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20250331.xsd EX-101.SCH 31366
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT skye-20250331_cal.xml EX-101.CAL 45702
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT skye-20250331_def.xml EX-101.DEF 124889
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20250331_lab.xml EX-101.LAB 471626
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20250331_pre.xml EX-101.PRE 303159
63 EXTRACTED XBRL INSTANCE DOCUMENT skye-20250331_htm.xml XML 414626
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42009 | Film No.: 25925872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)